Spectrum Pharmaceuticals, Talon Therapeutics deal

Spectrum will acquire a 90% stake in Talon for $11.3 million, or $0.056 per share, in cash up front. The price is an 85% discount to the company's $0.37 close

Read the full 303 word article

How to gain access

Continue reading with a
two-week free trial.